CVS Health Corporation $CVS Stock Holdings Increased by Hamlin Capital Management LLC

Hamlin Capital Management LLC raised its position in shares of CVS Health Corporation (NYSE:CVS) by 4.6% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 1,717,608 shares of the pharmacy operator’s stock after purchasing an additional 74,962 shares during the quarter. CVS Health comprises about 4.0% of Hamlin Capital Management LLC’s investment portfolio, making the stock its 11th largest position. Hamlin Capital Management LLC’s holdings in CVS Health were worth $177,687,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in CVS. Trust Asset Management LLC lifted its stake in CVS Health by 1.1% during the second quarter. Trust Asset Management LLC now owns 14,171 shares of the pharmacy operator’s stock worth $1,466,000 after purchasing an additional 149 shares during the last quarter. Balefire LLC bought a new stake in CVS Health during the second quarter valued at $267,000. Dynamic Advisor Solutions LLC increased its stake in CVS Health by 1.2% during the second quarter. Dynamic Advisor Solutions LLC now owns 36,441 shares of the pharmacy operator’s stock valued at $3,770,000 after purchasing an additional 437 shares during the last quarter. Baron Wealth Management LLC acquired a new stake in shares of CVS Health during the second quarter worth $326,000. Finally, GK Wealth Management LLC bought a new position in shares of CVS Health in the 2nd quarter worth about $307,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Buying and Selling at CVS Health

In other news, Director Larry Robbins sold 1,983,538 shares of the firm’s stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $94.45, for a total transaction of $187,345,164.10. Following the transaction, the director directly owned 6,213,261 shares of the company’s stock, valued at approximately $586,842,501.45. This trade represents a 24.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Tilak Mandadi sold 69,551 shares of CVS Health stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the sale, the executive vice president owned 10,133 shares in the company, valued at approximately $907,714.14. This represents a 87.28% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 3,441,551 shares of company stock valued at $323,703,977. Company insiders own 0.85% of the company’s stock.

CVS Health Trading Down 5.0%

CVS Health stock opened at $99.24 on Thursday. CVS Health Corporation has a 52-week low of $62.52 and a 52-week high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78. The firm has a market capitalization of $126.62 billion, a price-to-earnings ratio of 43.72, a PEG ratio of 1.02 and a beta of 0.61. The firm has a 50-day moving average price of $102.10 and a two-hundred day moving average price of $87.56.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The company had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. During the same quarter in the previous year, the company posted $1.81 earnings per share. The business’s revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Sell-side analysts expect that CVS Health Corporation will post 7.46 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date was Thursday, July 23rd. CVS Health’s payout ratio is 117.18%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of CVS Health from $88.00 to $92.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Piper Sandler reissued an “overweight” rating and issued a $113.00 target price on shares of CVS Health in a report on Monday, June 1st. Sanford C. Bernstein upped their target price on CVS Health from $94.00 to $106.00 and gave the company an “outperform” rating in a report on Tuesday, May 12th. Mizuho increased their price target on CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Finally, Royal Bank Of Canada raised their price target on CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. Twenty-one equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $105.67.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Strong quarterly beat: CVS reported adjusted EPS of $2.58, well above the roughly $1.86–$1.87 consensus, while revenue rose 7.3% year over year to $106.1 billion, exceeding estimates near $100 billion. All three major segments—insurance, pharmacy and health services—reportedly surpassed revenue expectations. CVS blows past estimates, hikes guidance as insurance unit continues to improve
• Positive Sentiment: Insurance turnaround is showing progress: Lower-than-expected medical costs and improved performance at Aetna helped drive the profit increase, while better-rated government health plans generated bonus payments. A more profitable pharmacy drug mix also supported results. CVS raises annual profit forecast on improved drug revenues
• Positive Sentiment: Guidance and cash flow increased: CVS raised 2026 adjusted EPS guidance to $7.90–$8.10 from $7.30–$7.50 and lifted operating cash-flow guidance to at least $11.5 billion from $9.5 billion. CVS Health reports strong second quarter results and raises full-year guidance
• Positive Sentiment: GLP-1 opportunity expanded: A new collaboration with Eli Lilly will broaden CVS’s direct-to-consumer weight-management services and access to Zepbound and other GLP-1 medications, potentially creating additional pharmacy and care-service revenue. CVS enhances direct-to-consumer weight-management offerings
• Neutral Sentiment: Despite the earnings beat, CVS’s valuation and recent rally may have raised investor expectations, making the market more sensitive to cautious commentary and execution risks.
• Negative Sentiment: Management remarks concerning the PBM unit reportedly prompted the initial gains to reverse. Investors may be concerned about Caremark’s competitive, pricing and margin outlook, limiting enthusiasm for the higher guidance. CVS Health reverses early gains after management remarks on PBM unit

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.